Given that p52 plasmid is a p100 construct with its C-terminal deletion (443–900-aa) [19, 20], above results clearly demonstrate that p100, but not p52, exhibits an inhibition of Cyclin D1 expression, cell cycle progression and anchorage-independent growth in human BC cells. This evidence concerns the gene NFKB2 and breast cancer.